3.20
price up icon2.56%   0.08
pre-market  プレマーケット:  3.18   -0.02   -0.63%
loading

Evotec Se Adr (EVO) 最新ニュース

pulisher
May 03, 2026

Boyd Gaming posts downbeat Q1 results, joins Coursera, Evotec and other big stocks moving lower in Friday's pre-market session - MSN

May 03, 2026
pulisher
Apr 30, 2026

Evotec SE Stock (DE0005664809): Q1 2026 Results Due Today - AD HOC NEWS

Apr 30, 2026
pulisher
Apr 29, 2026

Evotec nominates Wolfgang Hofmann to supervisory board By Investing.com - Investing.com Australia

Apr 29, 2026
pulisher
Apr 29, 2026

Evotec nominates Wolfgang Hofmann to supervisory board - Investing.com

Apr 29, 2026
pulisher
Apr 25, 2026

Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm

Apr 25, 2026
pulisher
Apr 25, 2026

Evotec names Claire Hinshelwood as CFO, replacing Paul Hitchin By Investing.com - Investing.com Australia

Apr 25, 2026
pulisher
Apr 24, 2026

Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday - Benzinga

Apr 24, 2026
pulisher
Apr 24, 2026

Evotec names Claire Hinshelwood as CFO, replacing Paul Hitchin - Investing.com

Apr 24, 2026
pulisher
Apr 21, 2026

Middle East Conflict Weighs on Markets: Food Supply Chains Become a Key Issue – MustGrow, K+S, Evotec, and BioNTech in the Spotlight - news.financial

Apr 21, 2026
pulisher
Apr 19, 2026

Evotec SE stock (DE0005664809): Is its drug discovery platform strong enough for biotech recovery? - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 19, 2026

Evotec SE stock (DE0005664809): Is its drug discovery pipeline strong enough to unlock biotech upsid - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 19, 2026

Evotec SE stock (DE0005664809): Is its drug discovery platform strong enough to unlock biotech upsid - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 19, 2026

Evotec SE stock (DE0005664809): Is its drug discovery partnership model strong enough for steady ups - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 18, 2026

Evotec SE stock (DE0005664809): Is its drug discovery partnership model strong enough for biotech re - AD HOC NEWS

Apr 18, 2026
pulisher
Apr 18, 2026

Evotec SE stock (DE0005664809): Is its drug discovery model strong enough to unlock biotech upside? - AD HOC NEWS

Apr 18, 2026
pulisher
Apr 15, 2026

Evotec appoints Ingrid Müller as chief operating officer - Investing.com

Apr 15, 2026
pulisher
Apr 14, 2026

Evotec SE stock (DE0005664809): Is its drug discovery model strong enough to unlock new upside? - AD HOC NEWS

Apr 14, 2026
pulisher
Apr 08, 2026

Evotec Q4 2025 slides: strong finish masks segment headwinds By Investing.com - Investing.com Australia

Apr 08, 2026
pulisher
Apr 08, 2026

BofA reiterates Evotec stock Underperform rating on execution concerns - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

Evotec (NASDAQ: EVO) pivots to asset-light model and boosts 2025 liquidity - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

Evotec Q4 2025 slides: strong finish masks segment headwinds - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

Earnings call transcript: Evotec SE ADR Q4 2025 sees revenue growth, stock surges - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

Evotec sees weak 2026 outlook after in-line 2025 results, $100 mln deal By Investing.com - Investing.com South Africa

Apr 08, 2026
pulisher
Apr 08, 2026

Evotec sees weak 2026 outlook after in-line 2025 results, $100 mln deal - Investing.com

Apr 08, 2026
pulisher
Apr 07, 2026

Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal - Benzinga

Apr 07, 2026
pulisher
Apr 05, 2026

Evotec's B2B Partner Search Initiative: Unlocking Strategic Collaborations in Drug Discovery for Nor - AD HOC NEWS

Apr 05, 2026
pulisher
Apr 01, 2026

Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 - ChartMill

Apr 01, 2026
pulisher
Apr 01, 2026

Evotec appoints Ashiq Khan as chief commercial officer - Investing.com

Apr 01, 2026
pulisher
Apr 01, 2026

Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer - ChartMill

Apr 01, 2026
pulisher
Mar 30, 2026

Evotec SE Stock: Drug Discovery Leader Faces Restructuring Challenges Ahead of Key Earnings - AD HOC NEWS

Mar 30, 2026
pulisher
Mar 25, 2026

Evotec SE stock faces pressure amid biotech sector volatility and partnership updates - AD HOC NEWS

Mar 25, 2026
pulisher
Mar 24, 2026

Evotec SE Stock Faces Pressure Amid Biotech Sector Headwinds and Pipeline Updates in Q1 2026 - AD HOC NEWS

Mar 24, 2026
pulisher
Mar 23, 2026

JustEvotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses - ChartMill

Mar 23, 2026
pulisher
Mar 12, 2026

Breaking News! Takeover speculation? BioNTech, Evotec, Vidac Pharma - news.financial

Mar 12, 2026
pulisher
Mar 10, 2026

FreightCar America Posts Downbeat Q4 Results, Joins BioNTech, PROG Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Mar 10, 2026
pulisher
Mar 06, 2026

Evotec Aktie | DE0005664809 | ETR:EVT | News & Aktienkurs | FRA:EVT - LYNX Online Broker

Mar 06, 2026
pulisher
Feb 03, 2026

Evotec shares surge 8% as Berenberg initiates with “buy” on partner value By Investing.com - Investing.com South Africa

Feb 03, 2026
pulisher
Jan 18, 2026

Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? - Finviz

Jan 18, 2026
pulisher
Jan 13, 2026

Financial Review: Evotec (NASDAQ:EVO) & Savara (NASDAQ:SVRA) - Defense World

Jan 13, 2026
pulisher
Jan 01, 2026

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Chartmill

Jan 01, 2026
pulisher
Dec 11, 2025

Taxes of Evotec SE Sponsored ADR – LSX:A0QZ3J - TradingView — Track All Markets

Dec 11, 2025
pulisher
Dec 08, 2025

EvotecHow Low A Company May Go While Still Being Attractive (NASDAQ:EVO) - Seeking Alpha

Dec 08, 2025
RDY RDY
$13.26
price down icon 0.67%
$22.99
price up icon 2.13%
RGC RGC
$27.27
price down icon 0.33%
$135.06
price up icon 0.74%
$15.52
price up icon 2.11%
$572.20
price down icon 1.55%
大文字化:     |  ボリューム (24 時間):